Prospective study · 2013
Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a "Waterloo"
Mondaini N, Fusco F, Cai T, Benemei S, Mirone V, Bartoletti R (2013). Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a "Waterloo". Urology. doi:10.1016/j.urology.2013.05.018
Of 120 men with lifelong PE offered dapoxetine, 20% declined to start and about 90% of those who started had stopped within a year, mostly because of disappointing effects, cost or side effects.
Summary
This prospective study followed 120 consecutive men (mean age 40.3) seeking medical treatment for lifelong premature ejaculation (PE) at an Italian clinic. All had normal erections. Each received a prescription for on-demand dapoxetine 30 mg, increased to 60 mg after three months if there was no response, and was reviewed at 1, 3, 6 and 12 months, with a questionnaire about reasons for stopping.
Twenty-four men (20%) chose not to start the medicine at all, most often because of fear of taking a "drug" (50%) or cost (25%). Of the 96 who started, 26% stopped after 1 month, 42.7% after 3 months, 18.7% at 6 months and 2% at 12 months; only 10.4% were still taking it after a year. The main reasons for stopping were effects below expectations (24.4%), cost (22.1%), side effects (19.8%), loss of interest in sex (19.8%) and lack of efficacy (13.9%).
Limitations
This was a single-centre study in one country without a comparison group, and reasons for stopping were chosen from a multiple-choice list. Cost and access depend heavily on the local health system.
What it means for you
A medicine that works in trials only helps if you are willing and able to keep taking it. Many men stop on-demand treatment within months, which is one reason guidelines and researchers pay attention to approaches that build a skill that does not depend on a tablet, and to combining medication with training rather than relying on a tablet alone.